Alcon said it is investing $250 million to expand its contact lens manufacturing facility in Atlanta, bringing with it an expected 250 jobs, according to the Atlanta Business Chronicle. Alcon has an 850,000 square foot facility in Johns Creek, a suburb of Atlanta, which employs 1,700 people “Alcon is the global leader in eye care, […]
Alcon
Alcon’s sluggish Q2 hits Novartis
(Reuters) — A weak performance from eyecare division Alcon, plus the strong dollar, hit Novartis (NYSE:NVS) in the 2nd quarter, scuppering hopes that the Swiss drugmaker would raise its 2015 financial outlook. The difficulties at Alcon reflected lower sales of contact lenses, intraocular lenses and surgical equipment, offsetting a solid showing in pharmaceuticals and an impressive sales […]
Alcon wins CE Mark for AcrySof IQ PanOptix trifocal lens
Alcon said last month that it won CE Mark approval in the European Union for its AcrySof IQ PanOptix trifocal intraocular lens. The lens is indicated for use in patients undergoing cataract surgery who need treatment for near, intermediate, and distance vision needs with a single lens, the Switzerland-based company said. “The AcrySof IQ PanOptix trifocal IOL […]
FDA releases final recs on legal exemptions for customized medical devices | Regulatory news for the week of September 29, 2014
Alcon wins date with FDA panel for AcrySof lens
Alcon Laboratories won a date before an FDA advisory panel in November to review the data behind its application for a new indication for its AcrySof IQ ReSTOR intraocular lens, the watchdog agency said today.
The AcrySof IQ ReSTOR lens is already approved in the U.S. to treat presbyopia and cataracts.
Novartis partners with Google on smart contact lenses
Alcon Labs issues hazard alert on certain intraocular lenses
Alcon Laboratories in conjunction with Australian healthcare regulators issued a warning on certain intraocular lenses after receiving reports of higher-than-expected rates of accelerated endothelial cell loss.
Survey: Heart docs say Edwards on track for solid heart valve growth | Wall Street Beat
Edwards Lifesciences (NYSE:EW) is on track for solid growth in the transcatheter aortic valve implant market, according to a survey of cardiologists conducted by Leerink Swann analysts.
Medical device companies: Who spends the most on R&D?
Across the medical device industry, R&D spending in 2011 increased despite a lethargic economy, job cuts and reorganization mandates by a number of big-name companies.
Med-tech in the OC: A Q&A with OCTANe’s Matthew Jenusaitis
Matthew Jenusaitis knows a little something about regional hotbeds of innovation in the med-tech space. Having spent 15 years at Boston Scientific Corp. (NYSE:BSX) in numerous executive marketing and general management positions, Jenusaitis once called Boston his home.
But when family lured him back West, he found himself ensconced in, dare we say, an even hotter space for medical device innovation – Orange County, a region of Southern California mostly known for postcard-pretty beaches, tourist attractions and MTV reality shows.
Feds probe Alcon in fraud case
The U.S. Dept. of Health & Human Services issued a subpoena to Novartis (NYSE:NVS) subsidiary Alcon Inc., seeking documents related to its marketing practices and payments to physicians.
The Sept. 23 subpoena is part of an HHS investigation probe into possible health care fraud, Novartis said in a regulatory filing.